Health Trials

Liver Cancer Registry Platform

ConditionsHepatocellular Carcinoma (HCC)Cholangiocarcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsoriOMEDICO AG

About this trial

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma (CCC) in Germany.

Eligibility criteria

Qualifiers

Confirmed hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCC) als early, intermediate or advanced/metastatic stage

Age ≥ 18 years

For participation in the PRO module: Before primary locoregional therapy or start of first systemic treatment

For no participation in the PRO module: No later than 8 weeks after primary locoregional therapy or start of first systemic treatment

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Physician's choice according to patient's needs.

Treatment groups

1,000 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Multiple sites all over germanyRecruiting Multiple SitesGermanyGermany

Sponsors and collaborators

iOMEDICO AG

Lead sponsor

Source ClinicalTrials.gov